Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion type Assertion NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_head.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion description "[We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132), IDH2 (R140 and R172), and c-CBL (exons 8 and 9) in 62 MPN patients (52 essential thrombocythemia (ET), five polycythemia vera (PV), and five primary myelofibrosis (PMF)) negative for both JAK2 (V617F and exon 12) and MPL (exon 10) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_provenance.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion evidence source_evidence_literature NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_provenance.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion SIO_000772 21904853 NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_provenance.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion wasDerivedFrom befree-20150227 NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_provenance.
- NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_assertion wasGeneratedBy ECO_0000203 NP286305.RAvUvawZB6rN_vGfKuhF8vmf3ltbsiWH0I_FMIsM8aPts130_provenance.